Skip to main content
AAN.com
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 17Number 5May 1967
Pages: 427
PubMed: 6067254

Publication History

Published online: May 1, 1967
Published in print: May 1967

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Margaret M. Hoehn, M.D.
From the Department of Neurology, College of Physicians and Surgeons, Columbia University, and the Neurological Service, New York Neurological Institute of the Columbia-Presbyterian Medical Center, New York City
Melvin D. Yahr, M.D.
From the Department of Neurology, College of Physicians and Surgeons, Columbia University, and the Neurological Service, New York Neurological Institute of the Columbia-Presbyterian Medical Center, New York City

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Clinical progression of Parkinson's disease in the early 21st century: Insights from the accelerating medicine partnership (AMP-PD) data, Parkinsonism & Related Disorders, 130, (107186), (2025).https://doi.org/10.1016/j.parkreldis.2024.107186
    Crossref
  2. Dual-task performance during the Timed Up and Go test in Parkinson's disease - the impact of freezing and cognition, Gait & Posture, 115, (14-20), (2025).https://doi.org/10.1016/j.gaitpost.2024.10.016
    Crossref
  3. Hardware synthesis of closed loop PID controlled L-DOPA model for automated drug delivery, Biomedical Signal Processing and Control, 100, (106840), (2025).https://doi.org/10.1016/j.bspc.2024.106840
    Crossref
  4. The beta-sitosterol beta-D-glucoside (BSSG) rat model of Parkinson's disease, Translational Models of Parkinson' s Disease and Related Movement Disorders, (187-201), (2025).https://doi.org/10.1016/B978-0-443-16128-5.00011-6
    Crossref
  5. Parkinson disease and Parkinsonism, Practical Approach to the Neurological Patient, (194-202.e3), (2025).https://doi.org/10.1016/B978-0-443-12642-0.00014-1
    Crossref
  6. Prevalence, Impact, and Screening Methods of Sarcopenia in Japanese Patients With Parkinson’s Disease: A Prospective Cross-Sectional Study, Cureus, (2024).https://doi.org/10.7759/cureus.65316
    Crossref
  7. Assessment of Pulmonary Functions in Parkinson's Disease and Unveiling the Role of Levodopa Therapy: A Cross-Sectional Study, Cureus, (2024).https://doi.org/10.7759/cureus.58662
    Crossref
  8. Dynamic Balance in Parkinson´s Disease Can be Ameliorated by External Focus of Attention, Studia sportiva, 18, 01, (2024).https://doi.org/10.5817/StS2024-1-9
    Crossref
  9. Evaluating the Effects of Bimanual Activities with and Without Motivational Strategies on Participation and Upper Extremity Function in Subjects with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial, Middle East Journal of Rehabilitation and Health Studies, 11, 4, (2024).https://doi.org/10.5812/mejrh-146978
    Crossref
  10. Which aerobic exercise is more effective in Parkinson's patients? Cycle ergometer versus body weight-supported treadmill, Turkish Journal of Physical Medicine and Rehabilitation, 70, 2, (241-250), (2024).https://doi.org/10.5606/tftrd.2024.11991
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share